These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3187925)

  • 1. [Dihydroquinidine metabolites after the administration in man of a delayed-action preparation].
    Flouvat B; Resplandy G; Roux A; Friocourt P; Viel C; Plat M
    Therapie; 1988; 43(4):255-61. PubMed ID: 3187925
    [No Abstract]   [Full Text] [Related]  

  • 2. Short- and long-acting oral quinidine preparations: clinical implications of pharmacokinetic differences.
    Woo E; Greenblatt DJ; Ochs HR
    Angiology; 1978 Mar; 29(3):243-50. PubMed ID: 646185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood levels of dihydroquinidine in man following oral administration of a delayed-action preparation].
    Maccari M; Lapeyre D; Maggi GC
    Farmaco Prat; 1979 Feb; 34(2):49-57. PubMed ID: 456541
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of quinidine and dihydroquinidine in humans.
    Hailey DM; Lea AR; Coles DM; Heaume PE; Smith WJ
    Eur J Clin Pharmacol; 1981; 21(3):195-9. PubMed ID: 7318878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of a long-acting hydroquinidine preparation].
    Guffanti E; Vaccarella A; Meregalli M
    Minerva Cardioangiol; 1982; 30(7-8):381-5. PubMed ID: 7133428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics and efficacy of delayed-action hydroquinidine in patients with ventricular extrasystole].
    Victor J; Turcant A; Tadei A; Allain P
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):163-6. PubMed ID: 2436547
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
    Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
    J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
    [No Abstract]   [Full Text] [Related]  

  • 9. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
    Accettura D; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Mastropasqua F; Caiati C; Rizzon P
    Cardiologia; 1987 Sep; 32(9):999-1003. PubMed ID: 2446764
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
    Ueda CT; Dzindzio BS
    Eur J Clin Pharmacol; 1979 Sep; 16(2):101-5. PubMed ID: 499305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human pharmacokinetic study of a sustained-release preparation of hydroquinidine: single and chronic administration].
    Flouvat B; Delhotal B; Kahn JC; Crouzette J; Dubourg O; Roux A; Fodor F; Bourdarias JP
    Therapie; 1984; 39(4):337-44. PubMed ID: 6484877
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiarrhythmic efficacy and tolerance of slow-release mexiletine in comparison with hydroquinidine retard].
    Fazio S; Villari B; Petitto M; Santomauro M; Iacono C; Celentano A; de Divitiis O
    Minerva Cardioangiol; 1987 Nov; 35(11):631-6. PubMed ID: 3444537
    [No Abstract]   [Full Text] [Related]  

  • 14. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P; De Toma L; Mangini SG; Scrutinio D; Lagioia R; De Nicolò M
    Cardiologia; 1983 Sep; 28(9):791-801. PubMed ID: 6398703
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of quinidine metabolites to electrophysiologic responses in human subjects.
    Kavanagh KM; Wyse DG; Mitchell LB; Gilhooly T; Gillis AM; Duff HJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):352-8. PubMed ID: 2776394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute bioavailability of quinidine in two sustained release preparations.
    Amlie JP; Storstein L; Olsson B; Fremstad D; Jacobsen S
    Eur J Clin Pharmacol; 1979 Aug; 16(1):45-8. PubMed ID: 499299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant.
    Pirro E; De Francia S; Banaudi E; Riggi C; De Martino F; Piccione FM; Giustetto C; Racca S; Agnoletti G; Di Carlo F
    Br J Clin Pharmacol; 2011 Dec; 72(6):982-4. PubMed ID: 21707701
    [No Abstract]   [Full Text] [Related]  

  • 18. Quinidine--a re-evaluation.
    Kay CF
    Med Clin North Am; 1966 Sep; 50(5):1221-30. PubMed ID: 5339487
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of arrhythmia with quinidine duriles].
    Ernst S
    Ther Ggw; 1970 Jul; 109(7):1019-36. PubMed ID: 5469934
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of quinidine bisulfate in the prevention of paroxysmal cardic arrhythmia].
    Pasini U; Netto MP; Diament J; Valada LP
    Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(5):205-8. PubMed ID: 5081834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.